State of New Jersey Common Pension Fund D Acquires 14,547 Shares of Bruker Corporation $BRKR

State of New Jersey Common Pension Fund D lifted its holdings in shares of Bruker Corporation (NASDAQ:BRKR) by 39.0% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 51,828 shares of the medical research company’s stock after purchasing an additional 14,547 shares during the quarter. State of New Jersey Common Pension Fund D’s holdings in Bruker were worth $2,135,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in the business. Moloney Securities Asset Management LLC bought a new position in shares of Bruker during the second quarter worth approximately $253,000. Ethic Inc. increased its holdings in shares of Bruker by 7.9% during the second quarter. Ethic Inc. now owns 9,882 shares of the medical research company’s stock worth $413,000 after purchasing an additional 720 shares during the period. VIRGINIA RETIREMENT SYSTEMS ET Al bought a new position in shares of Bruker during the second quarter worth approximately $721,000. Stanley Laman Group Ltd. increased its holdings in shares of Bruker by 13.9% during the second quarter. Stanley Laman Group Ltd. now owns 99,890 shares of the medical research company’s stock worth $4,115,000 after purchasing an additional 12,154 shares during the period. Finally, VELA Investment Management LLC increased its holdings in shares of Bruker by 80.0% during the second quarter. VELA Investment Management LLC now owns 123,591 shares of the medical research company’s stock worth $5,092,000 after purchasing an additional 54,928 shares during the period. 79.52% of the stock is owned by institutional investors.

Analysts Set New Price Targets

BRKR has been the topic of a number of recent analyst reports. Jefferies Financial Group set a $60.00 price objective on shares of Bruker and gave the company a “buy” rating in a research note on Monday, August 4th. Weiss Ratings reissued a “sell (d+)” rating on shares of Bruker in a research note on Wednesday, October 8th. Citigroup decreased their price objective on shares of Bruker from $40.00 to $38.00 and set a “neutral” rating on the stock in a research note on Monday, August 4th. Barclays decreased their price objective on shares of Bruker from $43.00 to $40.00 and set an “overweight” rating on the stock in a research note on Thursday, October 2nd. Finally, Wells Fargo & Company decreased their target price on shares of Bruker from $60.00 to $50.00 and set an “overweight” rating on the stock in a research note on Tuesday, August 5th. Five analysts have rated the stock with a Buy rating, five have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $51.00.

Bruker Price Performance

Shares of NASDAQ:BRKR opened at $37.74 on Thursday. The firm has a market cap of $5.73 billion, a PE ratio of 72.58, a price-to-earnings-growth ratio of 5.45 and a beta of 1.20. The firm’s fifty day moving average is $34.32 and its 200-day moving average is $37.00. The company has a debt-to-equity ratio of 1.31, a quick ratio of 0.70 and a current ratio of 1.61. Bruker Corporation has a 52 week low of $28.53 and a 52 week high of $64.64.

Bruker (NASDAQ:BRKR) last issued its quarterly earnings results on Monday, August 4th. The medical research company reported $0.32 EPS for the quarter, missing analysts’ consensus estimates of $0.33 by ($0.01). The business had revenue of $797.40 million for the quarter, compared to analyst estimates of $811.17 million. Bruker had a return on equity of 17.89% and a net margin of 2.31%.Bruker’s revenue for the quarter was down .4% on a year-over-year basis. During the same quarter last year, the firm posted $0.52 EPS. Bruker has set its FY 2025 guidance at 1.950-2.050 EPS. Sell-side analysts predict that Bruker Corporation will post 2.69 earnings per share for the current year.

Bruker Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, October 3rd. Stockholders of record on Tuesday, September 23rd were issued a dividend of $0.05 per share. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date was Tuesday, September 23rd. Bruker’s payout ratio is 38.46%.

Insider Activity at Bruker

In other news, Director Cynthia M. Friend sold 3,535 shares of Bruker stock in a transaction on Friday, September 12th. The shares were sold at an average price of $32.25, for a total transaction of $114,003.75. Following the transaction, the director owned 18,016 shares in the company, valued at approximately $581,016. The trade was a 16.40% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 27.30% of the company’s stock.

Bruker Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.